Results 61 to 70 of about 14,545 (184)

Moxibustion for diabetic gastroparesis: A protocol for a systematic review and meta-analysis

open access: yes, 2020
Moxibustion has been widely used to relieve diabetic gastroparesis. moxibustion has a significant effect in alleviating diabetic gastroparesis. The purpose of this systematic review is to evaluate the effectiveness and safety of moxibustion in treating ...
Jianyu You
core   +1 more source

Current status and research progress of diagnosis and treatment of gastroparesis after gastric cancer surgery

open access: yes生物医学转化
Radical surgery is the cornerstone for achieving curative outcomes in early and locoregionally advanced gastric cancer. However, while radical surgery removes the tumor, it also carries the risk of postoperative complications. Gastroparesis is one of the
Han Xue   +4 more
doaj   +1 more source

GLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To critically examine the evolving evidence on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonist tirzepatide as adjuncts to insulin therapy in type 1 diabetes (T1D), with particular emphasis on their benefit–risk balance in individuals with ...
Thales Rossatto   +2 more
wiley   +1 more source

Demographic and clinical variables between participants with gastroparesis symptoms and without gastroparesis symptoms.

open access: yes, 2018
Demographic and clinical variables between participants with gastroparesis symptoms and without gastroparesis symptoms.
Turki J. AlHarbi (6111560)   +2 more
core   +1 more source

Mechanism of action of FoxiangSan in diabetic gastroparesis: Gut microbiota and cAMP/PKA pathway

open access: yesHeliyon
Diabetic gastroparesis, a common complication of type 2 diabetes (T2DM), presents a significant treatment challenge. FoxiangSan is emerging as a potential therapy.
Jukai Huang   +3 more
doaj   +1 more source

Newly identified human aminoacyl‐tRNA synthetase complex interacting multifunctional protein 2 (AIMP2) loss‐of‐function mutations cause neurodevelopmental defects linked to cell death in a zebrafish model

open access: yesThe FEBS Journal, EarlyView.
Human AIMP2 mutations lead to severe neurodevelopmental defects and brain atrophy. Using patient‐derived fibroblasts from two individuals, we show decreased AIMP2 protein levels and overall protein synthesis. In a zebrafish loss‐of‐function model, the lack of AIMP2 leads to an increase in cell death and results in smaller brains.
Patrick Mullen   +10 more
wiley   +1 more source

Real‐world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire‐5

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn   +5 more
wiley   +1 more source

Management of Gastric Motility Disorder

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2018
Gastric motility disorder or gastroparesis is an objective slowing of gastrointestinal emptying syndrome, in the absence of mechanical obstruction, with cardinal symptoms such as rapid feeling of fullness, fullness sensation after eating, nausea ...
Mustika Dian Permana, Kaka Renaldi
doaj   +1 more source

Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature

open access: yes, 2016
There have been a number of agents that have been tried for treatment of gastroparesis over the past 3 decades, with varying levels of success.
Bantu, Likeselam   +3 more
core   +1 more source

Idiopathic Gastroparesis: Lifestyle Modifications Versus Pharmacotherapy [PDF]

open access: yes, 2020
Idiopathic gastroparesis is a chronic symptomatic motility disorder of the stomach of unknown cause characterized by delayed gastric emptying in the absence of mechanical obstruction, with the majority of gastroparesis cases being classified as ...
Schieffer, Rebecca K.
core   +1 more source

Home - About - Disclaimer - Privacy